Tudor Investment Corp ET AL purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 10,297 shares of the company's stock, valued at approximately $348,000.
A number of other large investors also recently bought and sold shares of TEM. Operose Advisors LLC purchased a new stake in shares of Tempus AI in the fourth quarter valued at approximately $25,000. Farther Finance Advisors LLC purchased a new stake in Tempus AI in the 4th quarter worth $34,000. Prestige Wealth Management Group LLC increased its holdings in Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after acquiring an additional 965 shares in the last quarter. NewEdge Advisors LLC acquired a new position in Tempus AI during the fourth quarter worth $49,000. Finally, First Horizon Advisors Inc. grew its position in shares of Tempus AI by 207.9% in the fourth quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock valued at $55,000 after purchasing an additional 1,108 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.
Analysts Set New Price Targets
Several research firms recently weighed in on TEM. JPMorgan Chase & Co. downgraded shares of Tempus AI from an "overweight" rating to a "neutral" rating and upped their price target for the stock from $50.00 to $55.00 in a research report on Tuesday, February 25th. Needham & Company LLC restated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research report on Wednesday. Wolfe Research cut Tempus AI from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Morgan Stanley raised their price objective on Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a report on Friday. Finally, Guggenheim reiterated a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $61.50.
View Our Latest Research Report on Tempus AI
Insider Transactions at Tempus AI
In other news, CEO Eric P. Lefkofsky sold 84,948 shares of the stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $70.02, for a total transaction of $5,948,058.96. Following the sale, the chief executive officer now owns 5,208,057 shares of the company's stock, valued at approximately $364,668,151.14. This represents a 1.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Ryan M. Bartolucci sold 6,059 shares of the firm's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $80.00, for a total transaction of $484,720.00. Following the completion of the transaction, the chief accounting officer now directly owns 47,000 shares of the company's stock, valued at approximately $3,760,000. The trade was a 11.42 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 4,237,561 shares of company stock worth $251,210,331. 27.60% of the stock is currently owned by insiders.
Tempus AI Trading Down 5.9 %
TEM stock opened at $61.34 on Friday. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45. The business has a fifty day moving average of $48.39 and a two-hundred day moving average of $50.97. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.
Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. The business's quarterly revenue was up 75.4% on a year-over-year basis. Analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.
Tempus AI Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.